Global Information
회사소개 | 문의

세계의 피브린 실란트 시장(2019-2023년)

Global Fibrin Sealants Market 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2018년 10월 상품 코드 351682
페이지 정보 영문 106 Pages
가격
US $ 2,500 ₩ 2,859,700 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,431,700 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,575,600 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,719,500 PDF by E-mail (Global license) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 피브린 실란트 시장(2019-2023년) Global Fibrin Sealants Market 2019-2023
발행일 : 2018년 10월 페이지 정보 : 영문 106 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계 피브린 실란트 시장은 2019-2023년간 8.09%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다.

세계의 피브린 실란트(Fibrin Sealants) 시장 현황 분석과 향후 예측을 제품 및 지역별로 제공하며, 시장 성장요인과 과제, 주요 동향, 주요 벤더 개요 등의 정보를 정리하여 전해드립니다.

제1장 주요 요약

제2장 본 보고서의 조사 범위

제3장 시장 구도

  • 시장 생태계
  • 시장의 특징
  • 시장 세분화 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모
  • 시장 규모와 예측

제5장 Five Forces 분석

제6장 제품별 시장 세분화

  • 제품별 시장 세분화
  • 제품별 비교
  • 패치 : 시장 규모와 예측
  • 액체 : 시장 규모와 예측
  • 기타 : 시장 규모와 예측
  • 시장 기회

제7장 고객 현황

제8장 지역 현황

  • 지역 분류
  • 지역 비교
  • 아메리카 : 시장 규모와 예측
  • 유럽, 중동 및 아프리카 : 시장 규모와 예측
  • 아시아태평양 : 시장 규모와 예측
  • 시장 기회

제9장 의사결정 프레임워크

제10장 시장 성장요인과 과제

  • 시장 성장요인
  • 시장이 해결해야 할 과제

제11장 시장 동향

제12장 벤더 구도

  • 개요
  • 파괴적 혁신

제13장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Baxter
  • CSL
  • Ethicon
  • Takeda Pharmaceutical

제14장 부록

  • 조사 방법
  • 약어 리스트

제15장 Technavio에 대해

LSH 18.11.02

About Fibrin Sealants

Fibrin sealants is a two-component substance, namely thrombin and fibrinogen that are used to control bleeding during surgical procedures.

Technavio's analysts forecast the Global Fibrin Sealants Market to grow at a CAGR of 8.09% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the fibrin sealants market. To calculate the market size, the report considers the revenue generated by the sale of fibrin sealant products across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Fibrin Sealants Market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Baxter
  • CSL
  • Ethicon
  • Takeda Pharmaceutical
  • Market driver
  • Increasing number of surgical procedures
  • For a full, detailed list, view our report

Market challenge

  • High cost of fibrin sealants
  • For a full, detailed list, view our report

Market trend

  • Strong clinical trial pipeline
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Patches - Market size and forecast 2018-2023
  • Liquid - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges
  • Market challenges

PART 11: MARKET TRENDS

  • Strong clinical trial pipeline
  • Adoption of minimally invasive and robotic surgeries
  • Competitive business strategy

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Baxter
  • CSL
  • Ethicon
  • Takeda Pharmaceutical

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Patches - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Patches - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Liquid - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Liquid - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: New applications of fibrin sealants at the University of Virginia, US
  • Exhibit 30: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Top 3 countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Country_Legend_3
  • Exhibit 40: Market opportunity
  • Exhibit 41: Appendectomy surgeries in European hospitals (per 100,000 inhabitants) in 2015
  • Exhibit 42: Product launch by companies
  • Exhibit 43: Average cost of fibrin sealants
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Baxter - Vendor overview
  • Exhibit 51: Baxter - Business segments
  • Exhibit 52: Baxter - Organizational developments
  • Exhibit 53: Baxter- Geographic focus
  • Exhibit 54: Baxter - Segment focus
  • Exhibit 55: Baxter - Key offerings
  • Exhibit 56: Baxter - Key customers
  • Exhibit 57: CSL - Vendor overview
  • Exhibit 58: CSL - Business segments
  • Exhibit 59: CSL - Organizational developments
  • Exhibit 60: CSL - Geographic focus
  • Exhibit 61: CSL - Segment focus
  • Exhibit 62: CSL - Key offerings
  • Exhibit 63: CSL - Key customers
  • Exhibit 64: Ethicon - Vendor overview
  • Exhibit 65: Ethicon - Product segments
  • Exhibit 66: Ethicon - Organizational developments
  • Exhibit 67: Ethicon - Segment focus
  • Exhibit 68: Ethicon - Key offerings
  • Exhibit 69: Ethicon - Key customers
  • Exhibit 70: Takeda Pharmaceutical - Vendor overview
  • Exhibit 71: Takeda Pharmaceutical - Organizational developments
  • Exhibit 72: Takeda Pharmaceutical - Geographic focus
  • Exhibit 73: Takeda Pharmaceutical - Key offerings
  • Exhibit 74: Takeda Pharmaceutical - Key customers
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: List of abbreviations
Back to Top
전화 문의
이용안내
 
BCC Research